Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine vs Propofol for Airway Patency in OSA
NCT02993718Completed
- Sponsor
- Seoul National University Bundang Hospital
- Start
- Jan 2015
- Primary completion
- Jun 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of dexmedetomidine, sponsored by Seoul National University Bundang Hospital. Primary endpoint: Occurrence of upper airway obstruction at 3 hours. Started Jan 2015; status: completed.
02
Drugs
dexmedetomidine
Beyond the preview
Go deeper on NCT02993718.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02993718.